Clinical Trial Update: IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1 [Phase 3]

View source ↗

Summary

Phase 3 trial of an interferon-free combination therapy for treatment-naive chronic hepatitis C patients (HCVerso1) completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2016-04-18